Log In
Print
BCIQ
Print
Print this Print this
 

NG2 GAD

  Manage Alerts
Collapse Summary General Information
Company Diamyd Medical AB
DescriptionGlutamic acid decarboxylase (GAD) gene delivered directly to nerve cells using NTDDS (nerve targeting drug delivery system)
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Non-viral vector
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat diabetes pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today